ChoiceSpine’s Tiger Shark Cervical Spacer Earns Additional 510(k)

ChoiceSpine, a privately held spinal device maker, gained an additional 510(k) clearance to the Tiger Shark Cervical Spacer System from the U.S. Food and Drug Administration (FDA).
 
Tiger Shark C is made of titanium alloy and constructed into an anatomical form, complementing vertebral body shape. The implant features the firm’s proprietary BioBond endplate coverage technology. Tiger Shark C has experienced great success since inception in 2018. The 510(k) clearance, adds additional footprint sizes that boost the ability to treat a wider variety of patient anatomies.
 
“We have had great success with our Tiger Shark C System thus far and we are excited to see where the line extension takes us to support more surgeons and their patients,” said Anderson Collins, VP of business development and international in a press release.
 
“The additional size offering for Tiger Shark C allows me to offer a more bespoke fit for patients with larger vertebral body endplate anatomy,” stated Matthew Hazzard, M.D. of Northside Hospital in Georgia.